Viewing Study NCT05926466

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:35 PM
Ignite Modification Date: 2026-02-11 @ 12:34 PM
Study NCT ID: NCT05926466
Status: RECRUITING
Last Update Posted: 2023-12-22
First Post: 2023-06-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: BTZ-043 Dose Evaluation in Combination and Selection
Sponsor: Michael Hoelscher
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tuberculosis, Pulmonary View
None Other Specified Pulmonary Tuberculosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tuberculosis View
None BTZ-043 View
None Bedaquiline View
None Delamanid View
None Moxifloxacin View
None Safety View
None Tolerability View
None Pharmacokinetics (PK) View
None Benzothiazinones View
None Pulmonary Tuberculosis View
None Dose-finding View
None Antitubercular agents View